Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Gilead initiates phase II trial of GS-9876 in patients with active rheumatoid arthritis

Oct. 6, 2016

GlaxoSmithKline presents bromodomain inhibitors

Oct. 5, 2016

TAK1 is a promising new target for osteoarthritis

Oct. 5, 2016

Coherus Biosciences regains rights for CHS-0214 from Shire

Sep. 28, 2016

FDA approves adalimumab biosimilar Amjevita

Sep. 26, 2016

Janssen Biotech submits BLA to the FDA for sirukumab

Sep. 26, 2016

Merck & Co. discloses IRAK-4 inhibitors

Sep. 26, 2016

GlaxoSmithKline prepares and tests bromodomain-containing protein inhibitors

Sep. 23, 2016

Daiichi Sankyo seeks Japanese approval for Pralia in rheumatoid arthritis

Sep. 23, 2016

Regen BioPharma's NR2F6 modulators show positive preclinical results

Sep. 22, 2016

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...